According to the agency’s 2024 fourth quarter workplace drug and alcohol report, there has been a concerning increase in the detection of amphetamine-type substances and opioids compared to the previous year. While THC (Cannabis) remains the most commonly detected substance at 59.1%, the prevalence of amphetamines has risen to 24.4% and opioids to 12.1%.
Glenn Dobson, the CEO of the Drug Detection Agency, emphasized the dangers of working under the influence of amphetamines, citing impaired vision, dizziness, and reduced coordination as major workplace hazards. He expressed particular concern about the rise in opioid use, drawing parallels to the crisis in America and its impact on workplace safety.
Several factors contribute to the surge in opioid abuse, including the overprescription of painkillers like Tramadol. Dobson also pointed to the commercialization of drugs and the influence of global gangs as driving forces behind the trend.
A recent survey by Massey University revealed that one in four frequent drug users had engaged in non-medical use of pharmaceuticals in the past six months. The misuse of ADHD medications, especially prevalent in Wellington, Otago, and Auckland, is linked to student populations and the party drug culture.
In light of these findings, companies are urged to prioritize creating a drug-safe workplace by implementing comprehensive drug and alcohol policies and providing relevant training. Open and honest discussions about safety and the implementation of fair testing programs are essential to effectively manage risks associated with drug abuse.
For more information, contact sam.henderson@thestar.co.nz
